An observational study in Cholangitis, Secondary Biliary, Cholangiocarcinoma and Obstructive Jaundice, sponsored by Al-Azhar University. Completed at 5 sites in 5 countries. Per ClinicalTrials.gov, last updated 2020-07-08.
Sponsored by Al-Azhar University · Observational
In this study, investigators aim to explore the status of advanced endoscopy in different endoscopy units all over the world.
In this study, investigators aim to explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details.
evaluate the validity of different GI societies recommendations applied in different GI endoscopy units on the prevention of SARS-CoV-2 nosocomial transmission and the overall impact of this recommendations on the service provided by each GI unit.
Target audience:
Objectives:
Primary objective:
1- To explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details.
Secondary objectives:
Process:
A questionnaire containing advanced endoscopy procedure details in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of advanced endoscopy practice in the studied countries.
All patients with digestive disorders referred for ERCP or EUS during the study period in the participating centers
Exclusion Criteria:
Patients who will have endoscopic retrograde cholangiopancreatography
Other: Endoscopic management according to standard of care
Patients who will have endoscopic ultrasound
Other: Endoscopic management according to standard of care
Endoscopic management according to standard of care by ERCP or EUS according to the indication in each case
Age, gender, nationality
Investigators will report the baseline demographic data (age, gender, nationality) of all patients.
Time frame: 3 months
Indication for procedure, status of SARS-CoV-2 infection
Investigators will report the baseline data clinical data (indication for procedure, status of SARS-CoV-2 infection) of all patients.
Time frame: 3 months
Complete blood count and liver functions tests
Investigators will report the baseline laboratory data (complete blood count and liver functions tests) of all patients.
Time frame: 3 months
procedure related complications
Investigators will report the procedure related complications.
Time frame: 3 months
Effect of COVID-19 precautions on procedure time
Investigators will report wether the precautions lead to increase timing of the procedure
Time frame: 3 months
Effect of COVID-19 precautions on staff number
Investigators will report wether the precautions affected staff number (increased or decreased)
Time frame: 3 months
Plan to share: Undecided — Investigators may share data after first publication
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Al-Azhar University